Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter

Reuters Health • The Doctor's Channel Daily Newscast

Insulin sensitizers reduce lean mass loss associated with diabetes

NEW YORK (Reuters Health) – Insulin sensitizers may reduce the accelerated loss in muscle mass and strength seen in elderly men with type 2 diabetes, according to a report in the September 16th online issue of Diabetes Care. “These findings require further studies of how insulin sensitizers (particularly...

Reuters Health • The Doctor's Channel Daily Newscast

Dopamine pretreatment may help donated hearts

NEW YORK (Reuters Health) – Cardiac allografts might function better when brain-dead organ donors are treated with low-dose dopamine, researchers report. They say the approach — already known to improve renal graft function — is worthy of testing in heart donors too. The effect “is...

Reuters Health • The Doctor's Channel Daily Newscast

Strategies outlined for neonatal screening for congenital heart disease

NEW YORK (Reuters Health) – A specially convened work group has concluded that routine screening of newborns for critical congenital heart disease, based on the detection of low oxygen saturation via pulse-oximetry monitoring, should begin,. In its report in the November issue of Pediatrics, the panel...

Reuters Health • The Doctor's Channel Daily Newscast

Adjuvanted H1N1 flu vaccine highly protective in children

NEW YORK (Reuters Health) – A single pediatric dose of adjuvanted vaccine against pandemic influenza A/H1N1 (pH1N1) is better than 80% effective at 10 days after administration for preventing hospitalization in children, a Canadian team reports in the November issue of Pediatrics. “In the context of...

Reuters Health • The Doctor's Channel Daily Newscast

Omega-3, antioxidant supplements may do more harm than good in acute lung injury

NEW YORK (Reuters Health) – Contrary to expectations, dietary supplementation with omega-3 (n-3) fatty acids and antioxidants does not improve outcomes in patients with acute lung injury. In fact, it may be harmful, according to a report published online October 5th by the Journal of the American Medical...

Reuters Health • The Doctor's Channel Daily Newscast

Targeted agents prolong life but don’t cure advanced kidney cancer

NEW YORK (Reuters Health) – In advanced renal cell cancer, targeted inhibitors of the vascular epithelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) pathways improve progression-free survival in both first-line and second-line settings. However, these treatments rarely yield complete...

Reuters Health • The Doctor's Channel Daily Newscast

Prothrombin concentrate reverses rivaroxaban anticoagulation

NEW YORK (Reuters Health) – In healthy volunteers, prothrombin complex concentrate reverses the anticoagulant effect of rivaroxaban. However, it does not alter the action of dabigatran, Dutch researchers report in a September 6th on-line paper in Circulation. Dr. Elise S. Eerenberg told Reuters Health...

Reuters Health • The Doctor's Channel Daily Newscast

Bariatric surgery improves cardiovascular risk profile

NEW YORK (Reuters Health) – Bariatric surgery and its associated weight loss significantly improve the cardiovascular risk profile of obese patients, according to findings published in the August 30th online American Journal of Cardiology. “The bariatric community has recognized the remarkable metabolic...

Reuters Health • The Doctor's Channel Daily Newscast

Pancreatic carcinoma risk increased after certain other primary cancers

NEW YORK (Reuters Health) – The risk of pancreatic adenocarcinoma is increased after the occurrence of certain other primary cancers, researchers report in the September 1st online Cancer. “Risk of pancreatic cancer should be assessed taking into account several predispositions, including...

Reuters Health • The Doctor's Channel Daily Newscast

In vitro gliadin challenge useful in ‘hard-to-diagnose’ celiac disease

NEW YORK (Reuters Health) – Challenging biopsied duodenal mucosa with gliadin, the toxic fraction of the gluten of wheat, can help establish a final diagnosis of celiac disease in cases in which sensitivity to gluten is suspected but unconfirmed by standard diagnostic tests, report researchers from...